Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004728 · ClinicalTrials.gov registry record · Phase 3
Aspirin Or Warfarin To Prevent Stroke
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Terminated
- Registry status
- Phase 3
- Development phase
NCT00004728 is a Phase 3 study that was terminated before completion, run by National Institute of Neurological Disorders and Stroke (NINDS).
The verdict
NCT00004728, a Phase 3 study, was terminated before completion, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- TERMINATED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
Interventions
- DRUG Aspirin
- DRUG Warfarin
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2003-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004728
The ClinicalTrials.gov registry entry for NCT00004728 describes a study currently listed as terminated, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aspirin is the first listed.
NCT00004728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004728 about?
NCT00004728 is a clinical study titled "Aspirin Or Warfarin To Prevent Stroke". The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
What is the current status of trial NCT00004728?
This trial is currently terminated. It is a Phase 3 study. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00004728?
The interventions under investigation include: Aspirin (DRUG), Warfarin (DRUG).
Who is sponsoring clinical trial NCT00004728?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.